证券记录 · 已归档季度
ATR
AptarGroup, Inc. · Healthcare · Medical - Instruments & Supplies
21被追踪持有人
+2Δ持有人
26.07M持有股份
$3.48B报告持仓市值
+3新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +10.5% ·
股份流向 -2.5% ·
净新建仓位 +4.8%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 120 | -2 | 42.63M | $5.34B | +4 | −7 |
| Q1 2026 | 126 | -2 | 40.91M | $5.15B | +4 | −7 |
| Q4 2025 | 127 | -1 | 43.99M | $5.36B | +2 | −2 |
| Q3 2025 | 21 | +2 | 26.07M | $3.48B | +3 | −2 |
| Q2 2025 | 17 | -1 | 21.99M | $3.45B | n/a | −1 |
| Q1 2025 | 15 | +2 | 6.12M | $916.34M | +2 | n/a |
| Q4 2024 | 13 | 0 | 5.71M | $901.59M | n/a | n/a |
| Q3 2024 | 12 | 0 | 3.13M | $504.15M | n/a | n/a |
| Q2 2024 | 12 | n/a | 3.26M | $461.78M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 6.96M | -1.7% | $930.46M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (被动) | 6.25M | +0.2% | $835.36M | 0.0% | ▲ Add | 2 | SEC ↗ ×17 |
| 3 | Morgan Stanley ✦ | 4.25M | n/a | $568.28M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 4 | State Street Global Advisors ✦ (被动) | 2.77M | -3.3% | $370.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.60M | -8.3% | $214.38M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Fidelity (FMR) ✦ | 1.50M | -27.0% | $200.92M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 7 | JPMorgan Chase ✦ | 1.11M | n/a | $148.14M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 8 | AQR Capital Management ✦ | 536.93K | +32.5% | $71.32M | 0.0% | ▲ Add | 6 | SEC ↗ ×6 |
| 9 | Millennium Management ✦ | 401.85K | -15.5% | $53.71M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 147.96K | +134.1% | $19.78M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Goldman Sachs Group ✦ | 139.71K | n/a | $18.67M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Renaissance Technologies ✦ | 115.10K | +23.6% | $15.38M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 84.78K | +631.4% | $11.33M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | T. Rowe Price ✦ | 50.11K | +7.6% | $6.70M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 41.69K | -41.2% | $5.57M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 29.95K | 新增 | $4.00M | 0.0% | New | 1 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 27.89K | -11.1% | $3.73M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 18.57K | 新增 | $2.48M | 0.0% | New | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 14.70K | -1.6% | $1.96M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 4.72K | -54.7% | $631,544 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Marshall Wace ✦ | 4.54K | 新增 | $606,816 | 0.0% | New | 1 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $4.00M | 0.0% |
| Bridgewater Associates | $2.48M | 0.0% |
| Marshall Wace | $606,816 | 0.0% |
已清仓
| Norges Bank | $118.18M | 曾为 0.0% |
| Gotham Asset Management | $2.24M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 538 持有人, 58.90M 股份, $7.20B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 02
Vinczeller Shiela
Officer · 765 股 · $99,733
Aug 27
Touya Gael
Officer · 3.42K 股 · $456,546
Aug 27
Touya Gael
Officer · 325 股 · $43,730
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 12
SC 13G/A: MORGAN STANLEY
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据